Midostaurin In Acute Myeloid Leukemia: An Evidence-Based Review And Patient Selection

Fms-related-tyrosine kinase 3 (FLT3) mutations occur in approximately a third of acute myeloid leukemia (AML) patients and confer an adverse prognosis. Numerous studies have evaluated FLT3 targeting as single agent and in combination approaches in frontline and relapsed AML. At this time, midostauri...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Manag Res
Main Authors: Abbas, Hussein A, Alfayez, Mansour, Kadia, Tapan, Ravandi-Kashani, Farhad, Daver, Naval
Format: Artigo
Sprog:Inglês
Udgivet: Dove 2019
Fag:
Review
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6782026/
https://ncbi.nlm.nih.gov/pubmed/31632141
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S177894
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker